Football player cleared by cardiologist after missing time due to COVID-related myocarditis

Michael Walter | | Cardiovascular Business | COVID-19
Covid Test

Tommy Sweeney, a professional football player for the Buffalo Bills, has been cleared by his cardiologist after developing myocarditis during the 2020 campaign and missing much of the season. The myocarditis, Sweeney’s doctors determined, was related to his bout with COVID-19.

Chris Brown, a journalist covering the Bills, reported the update online. He noted that Sweeney has already been working out with the team and is expected to be fully active when training camp begins in July.

When it was first announced in November 2020, Sweeny’s myocarditis diagnosis was seen as a significant development; he was the first NFL player to come down with myocarditis following a COVID-19 diagnosis.

“It's unfortunate, but we know that he's a good football player and we know he's a guy that we believe in and can't wait to get back on the field when we can here,” Sean McDermott, head coach of the Bills, said at the time.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Death from heart disease more common in rural areas—what can cardiologists do?
FDA wants new heart damage warnings added to COVID-19 vaccines
PET imaging reveals long-term heart and lung damage from COVID-19
Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor
COVID-19 linked to accelerated plaque growth, long-term risk of heart attack or stroke

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.